Hyperhomocysteinemia is a risk factor for arterial endothelial dysfunction

被引:0
|
作者
Woo, KS
Chook, P
Lolin, Y
Cheung, ASP
Chan, LLT
Sun, YY
Sanderson, JE
Celermajer, DS
机构
[1] CHINESE UNIV HONG KONG,HONG KONG,HONG KONG
[2] UNIV SYDNEY,SYDNEY,NSW 2006,AUSTRALIA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:92089 / 92089
页数:1
相关论文
共 50 条
  • [1] Hyperhomocysteinemia and Endothelial Dysfunction
    Cheng, Zhong-Jian
    Yang, Xiaofeng
    Wang, Hong
    CURRENT HYPERTENSION REVIEWS, 2009, 5 (02) : 158 - 165
  • [2] Hyperhomocysteinemia is a risk factor for venous and arterial thrombosis
    Makris, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 : 18 - 20
  • [3] Hyperhomocysteinemia:: a novel risk factor for erectile dysfunction
    Demir, Tevfik
    Comlekci, Abdurrahman
    Demir, Omer
    Gulcu, Aytac
    Calypkan, Sezer
    Argun, Leyla
    Secil, Mustafa
    Yepil, Sena
    Esen, Adil
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2006, 55 (12): : 1564 - 1568
  • [4] Hypertriglyceridemia is a risk factor for arterial endothelial dysfunction in asymptomatic westernized Chinese
    Woo, KS
    Chook, P
    Chan, SW
    Lam, CWK
    Celermajer, DS
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 245A - 245A
  • [5] Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans
    Woo, KS
    Sanderson, JE
    Sun, YY
    Chook, P
    Cheung, ASP
    Chan, LT
    Metreweli, C
    Lolin, YI
    Celermajer, DS
    CIRCULATION, 2000, 101 (12) : E116 - E116
  • [6] Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans
    Woo, KS
    Chook, P
    Lolin, YI
    Cheung, ASP
    Chan, LT
    Sun, YY
    Sanderson, JE
    Metreweli, C
    Celermajer, DS
    CIRCULATION, 1997, 96 (08) : 2542 - 2544
  • [7] Hyperhomocysteinemia: a risk factor for arterial and venous thrombotic disease
    Cattaneo, M
    INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH, 1997, 27 (03): : 139 - 144
  • [8] Hyperhomocysteinemia, endothelial dysfunction, and cardiovascular risk: the potential role of ADMA
    Lentz, SR
    Rodionov, RN
    Dayal, S
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (04) : 61 - 65
  • [9] Endothelial dysfunction as a factor leading to arterial hypertension
    Drozdz, Dorota
    Drozdz, Monika
    Wojcik, Malgorzata
    PEDIATRIC NEPHROLOGY, 2023, 38 (09) : 2973 - 2985
  • [10] Endothelial dysfunction as a factor leading to arterial hypertension
    Dorota Drożdż
    Monika Drożdż
    Małgorzata Wójcik
    Pediatric Nephrology, 2023, 38 : 2973 - 2985